Sponsor:
M.D. Anderson Cancer Center
Code:
NCT04623931
Conditions
Anaplastic Astrocytoma, IDH-Wildtype
Anaplastic Oligoastrocytoma
Anaplastic Oligodendroglioma
Diffuse Astrocytoma, IDH-Wildtype
Glioblastoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Quality-of-Life Assessment
Questionnaire Administration
Radiation Therapy
Temozolomide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-01-01.